Healthcare Services

Diverticulitis Disease Market Industry Analysis Covering Trends, Drivers, And Future Outlook

May 28, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Market Size Is Forecasted For The Diverticulitis Disease Market By 2030 Based On Its 2026 Value?

The diverticulitis disease market size has seen significant expansion over recent years. It is forecast to rise from $2.02 billion in 2025 to $2.21 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.0%. This historical growth can be ascribed to factors including an aging population, low fiber dietary habits, limited early diagnosis, hospital-centric treatment models, and a rising prevalence of gastrointestinal disorders.

The diverticulitis disease market is projected to experience substantial expansion in the coming years, forecast to reach $3.22 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.9%. This growth over the forecast period is attributable to factors such as increased awareness of preventive digestive health, enhanced access to imaging, the expansion of outpatient care, a decrease in surgical intervention rates, and a greater emphasis on lifestyle adjustments. Key trends expected during this period involve a rise in the diagnosis of uncomplicated diverticulitis, a growing inclination towards conservative and outpatient management strategies, increased adoption of imaging-based diagnostics, the broadening of antibiotic and supportive care treatments, and heightened awareness regarding dietary and lifestyle management.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12990&type=smp

What Market Drivers Are Helping Shape The Diverticulitis Disease Market Expansion?

The increasing prevalence of smoking addiction is projected to drive the expansion of the diverticulitis disease market in the future. Smoking addiction describes a compulsory dependency on nicotine products such as cigarettes, vapes, and various other tobacco items. This rise in smoking addiction is largely due to aggressive promotional efforts, greater societal acceptance, stress-induced triggers, and the expanding availability of e-cigarettes and vaping devices. Diverticulitis management aligns with this pattern, given that smoking diminishes blood flow to the colon and exacerbates the risk and seriousness of diverticular disease, thereby increasing the demand for diagnostic and therapeutic solutions. For instance, in October 2024, according to the European Respiratory Society’s (ERS), a Switzerland-based non-profit organization, a study covering smoking trends among young people revealed a significant rise in smoking rates, with 22.5% of respondents smoking in 2022 compared to 40.1% in 2024. Therefore, the growing incidence of smoking addiction will stimulate the growth of the diverticulitis disease market.

How Is The Diverticulitis Disease Market Examined Through Segment Analysis?

The diverticulitis disease market covered in this report is segmented –

1) By Type: Uncomplicated, Complicated

2) By Diagnosis: Computed Tomography (Ct) Scan, Ultrasound, Urine Test, Blood Test

3) By Treatment: Medications, Surgery, Supportive Care, Penicillin Antibiotic, Antibiotics, Dietary Supplements, Intravenous (Iv) Fluids

4) By End-User: Specialty Centers, Hospitals, Research Centers

Subsegments:

1) By Uncomplicated: Outpatient Treatment, Dietary Management, Antibiotic Therapy

2) By Complicated: Hospitalization, Surgical Intervention, Intravenous Antibiotics, Abscess Drainage

Which Trends Are Influencing The Direction Of The Diverticulitis Disease Market?

Leading companies operating in the diverticulitis disease market are engaged in developing innovative drugs and securing their approval to sustain their market position. Such drug development has the potential to lead to the creation of more effective treatments for diverticulitis, thereby reducing the risk of complications and improving patient outcomes. For instance, in April 2023, the United States Food and Drug Administration, a US-based federal organization, approved Seres’ microbiota drug for recurrent gut infections. This specific drug is formulated to treat recurring gut infections and to prevent the recurrence of Clostridioides difficile (C. diff.) infections in adults aged 18 and over. The endorsement of Vowst was established on a clinical trial that included 346 patients with recurrent CDI. The trial’s findings indicated that patients who received Vowst were considerably less prone to experiencing a recurrence of the infection than those who were given a placebo. The medication is consumed orally and is rooted in microbiota comprising Firmicutes spores, which are known for their contribution to a healthy microbiome capable of resisting C. diff. colonization.

Which Companies Form The Competitive Landscape Of The Diverticulitis Disease Market?

Major companies operating in the diverticulitis disease market are Pfizer Inc., Johnson and Johnson, F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma, Eisai Co. Ltd., Sun Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Company, Cipla Limited, Hikma Pharmaceuticals PLC, Endo Pharmaceuticals, Aspen Pharmacare, Zydus Lifesciences, Lupin Limited, Glenmark Pharmaceuticals, Alkem Laboratories, Torrent Pharmaceuticals Ltd.

Access The Complete Diverticulitis Disease Market Report:

https://www.thebusinessresearchcompany.com/report/diverticulitis-disease-global-market-report

Which Region Contributes The Most To The Diverticulitis Disease Market?

North America was the largest region in the diverticulitis disease market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the diverticulitis disease market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Diverticulitis Disease Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=12990&type=smp

Browse Through More Reports Similar to the Global Diverticulitis Disease Market 2026, By The Business Research Company

Intestinal Pseudo Obstruction Treatment Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/intestinal-pseudo-obstruction-treatment-global-market-report

Intestinal Pseudo Obstruction Treatment Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/intestinal-pseudo-obstruction-treatment-global-market-report

Ulcerative Colitis Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/ulcerative-colitis-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795